Cutis · 2002
Aminolevulinic acid hydrochloride with photodynamic therapy: efficacy outcomes and recurrence 4 years after treatment.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fowler Joseph F, Zax Robert H
Аннотация
The safety and efficacy of treating individuals who presented with multiple actinic keratosis (AK) lesions with 5-aminolevulinic acid (ALA) in combination with photodynamic therapy (PDT) were documented in a phase III trial. This report highlights results of this phase III trial and reviews 4 specific cases of sustained AK lesion clearance 4 years after treatment with ALA/PDT Long-term recurrence data were collected from patients who participated in clinical trials of ALA/PDT Long-term evaluation extended to 36 to 48 months (4 years) supports primary efficacy findings of the phase III pivotal trial, with a low incidence of AK recurrence in patients treated with ALA/PDT
Предметные рубрики MeSH
Administration, CutaneousAdultAgedAminolevulinic AcidClinical Trials, Phase II as TopicFacial DermatosesFemaleHumansKeratosisLongitudinal StudiesMaleNeoplasm Recurrence, LocalPhotochemotherapyPhotosensitizing AgentsRandomized Controlled Trials as TopicScalp DermatosesSeverity of Illness IndexSingle-Blind MethodTreatment Outcome